新闻

Rieckermann recently hosted the second session of their new webinar series, this time discussing the topic “Scaling Biosimilar Production: Technical Challenges & Considerations.” This session provided....

Rieckermann is proud to welcome a new member to the Group. Effective Friday, February 14, 2025, JR New Horizons, Rieckermann’s independent investment arm, was able to acquire a renowned technology leader in ...

Rieckermann is pleased to embark on a new strategic partnership with Pamarco, a global leader in anilox products and services. This partnership will significantly expand both companies’ collective market presence and ...

Rieckermann is thrilled to announce the signing of a contract with the VNVC Vaccine And Biological Manufacturing Joint Stock Company to design their new vaccine and biological products manufacturing facility in Long An, Vietnam...